Form 4/A for CAC CAMDEN NATIONAL CORP
Accepted 2022-09-02 00:00:00 ET · period of report 2022-03-18 · accession 0000750686-22-000235 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2022-09-02 | 2022-03-18 | CAC | Flanagan David C | Dir | A - Grant | $49.02 | +333 | 18.9K | +2% | +$16.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-18 | A | A | 333 | $49.02 | 18,856.07 | D | — | — | (F2) Shares acquired under Camden National Corporation's 2012 Equity and Incentive Plan in lieu of director fees. (F3) Consists of 145.09 shares acquired since last filing as a result of participation in the Company's dividend reinvestment program. |